Breaking News

SCHOTT Expands U.S. Ops After Successful Year

Plans another record investment of $450 million to fuel growth and meet demand in top performing areas including SCHOTT’s pharmaceutical solutions.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SCHOTT, a specialty glass and international technology group, grew sales in the U.S. by 11% in 2021 to more than $530.6 million. In 2021, SCHOTT also increased its number of employees in the U.S. by nearly 100 and increased investments by almost $3 million.   “We adjusted our strategy to focus on the U.S. and activities in markets where we anticipate long-term growth. We have already recognized gains from that pivot and are well positioned to have an even better year in 2022,” said Bill James,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters